Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Internal Medicine (Tokyo, Japan)|November 18, 2016
Cases with Refractory Ascites and a Delayed Response to TolvaptanSatoru Hagiwara, Naoshi Nishida, Hirokazu Chishina, et al.
Cancers|October 14, 2022
Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological ResponseYasunori Minami, Tomoko Aoki, Hirokazu Chishina, et al.
Interventional Radiology (Higashimatsuyama-Shi (Japan)|May 4, 2026
Double-balloon (CANDIS) Retrograde Transvenous Obliteration Improves Hepatic Functional Reserve Compared with the Conventional MethodTomoko Aoki, Masakatsu Tsurusaki, Naoshi Nishida, et al.
Ultrasound in Medicine & Biology|July 16, 2021
Can the Entire Ablative Hyperechoic Zone be Regarded as a Necrotic Lesion After Radiofrequency Ablation of the Liver?Yasunori Minami, Masahiro Morita, Hirokazu Chishina, et al.
Cancers|May 16, 2023
Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular CarcinomaMasahiro Morita, Naoshi Nishida, Tomoko Aoki, et al.
Cancers|May 16, 2023
Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in CholangiocarcinomaNaoshi Nishida, Tomoko Aoki, Masahiro Morita, et al.
Cancers|October 23, 2020
Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD-1/PD-L1 Checkpoint BlockadeTomoko Aoki, Masatoshi Kudo, Kazuomi Ueshima, et al.
Oncology|November 28, 2014
Efficacy and safety of telaprevir-based antiviral treatment for elderly patients with hepatitis C virusMasahiro Takita, Satoru Hagiwara, Masatoshi Kudo, et al.
Liver Cancer|February 12, 2024
Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular CarcinomaTomoko Aoki, Masatoshi Kudo, Kazuomi Ueshima, et al.
Cells|November 27, 2021
Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver DiseaseSatoru Hagiwara, Naoshi Nishida, Kazuomi Ueshima, et al.
Pageof 6